The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR)
NCT04000789 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96
Last updated 2019-06-27
Summary
Commonly know that one of the complications caused by Diabetes Mellitus (DM) is microangiopathy. Microangiopathy in the long term may lead to neuropathy of the corneal nerves. Neuropathy of the cornea will lead to dry eyes in DM patient. One of the artificial tears used in treating dry eyes is sodium hyaluronate. But until recently no research had been done in examining the effect of giving combination of sodium hyaluronate, vitamin A and vitamin E in dry eyes. The antioxidant, and capability of vitamin A and E in promoting cell proliferation may alleviate the symptoms of dry eyes. In this paper we used Ocular Surface Disease Index (OSDI), Tear Break Up time, Schirmer I test and impression cytology to assess baseline and 28 days post therapy in patient with Non-Proliferative Diabetic Retinopathy (NPDR), and Proliferative Diabetic Retinopathy (PDR)
Conditions
- Non-Proliferative Diabetic Retinopathy
- Proliferative Diabetic Retinopathy New Vessels on Disc
- Dry Eye Syndromes
Interventions
- DRUG
-
Sodium Hyaluronate, Vitamin A, Vitamin E
Eye drops consisting of combination of Sodium Hyaluronate, Vitamin A, Vitamin E will be . given to patients in control groups
Sponsors & Collaborators
-
Dr Cipto Mangunkusumo General Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
More Related Trials
-
Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR
NCT04103671 ·Status: RECRUITING ·Phase: NA
-
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
NCT00130845 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density
NCT03361709 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Pilot Study to Assess the Preliminary Efficacy of EDTA Eye Drops on Band Keratopathy
NCT03985371 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
NCT00131144 ·Status: COMPLETED ·Phase: PHASE3
-
Laser and Antioxidant Treatment of Diabetic Macular Edema
NCT00055042 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness Of Suprachoroidal Injection In Diabetic Macular Edema
NCT06449768 ·Status: ACTIVE_NOT_RECRUITING
-
Anti-inflammatory Effect of Curcumin, Homotaurine, Vitamin D3 on Human Vitreous in Patients With Diabetic Retinopathy
NCT04378972 ·Status: COMPLETED
-
Dyslipidemia and Diabetic Retinopathy
NCT03403283 ·Status: COMPLETED
-
Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients
NCT04932213 ·Status: COMPLETED ·Phase: PHASE3
-
Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
NCT05383209 ·Status: COMPLETED ·Phase: PHASE2
-
Laser and Medical Treatment of Diabetic Macular Edema
NCT00027287 ·Status: COMPLETED ·Phase: PHASE1
-
Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD
NCT02684578 ·Status: COMPLETED ·Phase: PHASE2
-
Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser
NCT00668239 ·Status: COMPLETED ·Phase: NA
-
Topical Insulin for Glaucoma
NCT05206877 ·Status: RECRUITING ·Phase: PHASE1
-
A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema
NCT00369486 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy
NCT00849537 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular Edema
NCT00407849 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
NCT00367133 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy
NCT01921192 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of a Therapy With INTRAVIT® Tablets in Patients With Diabetic Retinopathy
NCT04742829 ·Status: UNKNOWN ·Phase: NA
-
Intravitreal and Intracameral DEX in NPDR
NCT06951087 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy
NCT04674254 ·Status: COMPLETED ·Phase: PHASE4
-
Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy
NCT01373476 ·Status: COMPLETED ·Phase: PHASE2
-
Specular Microscopy in Patients With Proliferative Diabetic Retinopathy
NCT05838898 ·Status: UNKNOWN